# GCM Grosvenor Inc.: overview

GCMG · Nasdaq · CIK 1819796 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gcmg.md) · [Financials](/companies/gcmg/financials.md) · [Filings](/companies/gcmg/filings.md) · [Insiders](/companies/gcmg/insiders.md)

Latest reported revenue: [$134.3m](/filings/0001819796-26-000028.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001819796-26-000028).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [123](/filings/0001819796-25-000025.md) | [165 d](/filings/0001819796-26-000010.md) | [126](/filings/0001819796-26-000024.md) | [120](/filings/0001819796-26-000028.md) | [135](/filings/0001819796-25-000025.md) | [177 d](/filings/0001819796-26-000010.md) | [125](/filings/0001819796-26-000024.md) | [134](/filings/0001819796-26-000028.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [20.3%](/filings/0001819796-25-000025.md) | [26.4% d](/filings/0001819796-26-000010.md) | [12.2%](/filings/0001819796-26-000024.md) | [16.1%](/filings/0001819796-26-000028.md) | [32.7%](/filings/0001819796-25-000025.md) | [30.9% d](/filings/0001819796-26-000010.md) | [16.4%](/filings/0001819796-26-000024.md) | [26.4%](/filings/0001819796-26-000028.md) |
| Net margin | % | [3.4%](/filings/0001819796-25-000025.md) | [4.6% d](/filings/0001819796-26-000010.md) | [0.4%](/filings/0001819796-26-000024.md) | [12.9%](/filings/0001819796-26-000028.md) | [7.8%](/filings/0001819796-25-000025.md) | [10.7% d](/filings/0001819796-26-000010.md) | [4.4%](/filings/0001819796-26-000024.md) | [7.1%](/filings/0001819796-26-000028.md) |
| Diluted EPS | $ per share | [0.03](/filings/0001819796-25-000025.md) | not reported | [(0.02)](/filings/0001819796-26-000024.md) | [0.05](/filings/0001819796-26-000028.md) | [0.16](/filings/0001819796-25-000025.md) | not reported | [0.06](/filings/0001819796-26-000024.md) | [0.12](/filings/0001819796-26-000028.md) |
| Free cash flow | $m | [62.2 d](/filings/0001819796-25-000025.md) | [37.0 d](/filings/0001819796-26-000010.md) | [32.1](/filings/0001819796-26-000024.md) | [40.8 d](/filings/0001819796-26-000028.md) | [78.3 d](/filings/0001819796-25-000025.md) | [23.9 d](/filings/0001819796-26-000010.md) | [47.9](/filings/0001819796-26-000024.md) | [36.3 d](/filings/0001819796-26-000028.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [532](/filings/0001819796-24-000005.md) | [447](/filings/0001819796-25-000006.md) | [445](/filings/0001819796-26-000010.md) | [514](/filings/0001819796-26-000010.md) | [558](/filings/0001819796-26-000010.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [20.6%](/filings/0001819796-24-000005.md) | [18.0%](/filings/0001819796-25-000006.md) | [(2.7%)](/filings/0001819796-26-000010.md) | [14.3%](/filings/0001819796-26-000010.md) | [23.9%](/filings/0001819796-26-000010.md) |
| Net margin | % | [4.0%](/filings/0001819796-24-000005.md) | [4.4%](/filings/0001819796-25-000006.md) | [2.9%](/filings/0001819796-26-000010.md) | [3.6%](/filings/0001819796-26-000010.md) | [8.1%](/filings/0001819796-26-000010.md) |
| Diluted EPS | $ per share | [0.28](/filings/0001819796-24-000005.md) | [0.28](/filings/0001819796-25-000006.md) | [(0.28)](/filings/0001819796-26-000010.md) | [0.03](/filings/0001819796-26-000010.md) | [0.42](/filings/0001819796-26-000010.md) |
| Free cash flow | $m | [178](/filings/0001819796-24-000005.md) | [216](/filings/0001819796-25-000006.md) | [88.3](/filings/0001819796-26-000010.md) | [132](/filings/0001819796-26-000010.md) | [175](/filings/0001819796-26-000010.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/gcmg/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [CANTOR FITZGERALD, L. P.](/funds/1024896.md) | 2026-06-30 | $79.4m | 6,451,535 |  | Unchanged |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $66.4m | 5,399,124 |  | Added +122,296 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $58.6m | 4,764,605 |  | Added +252,291 |
| [ARIEL INVESTMENTS, LLC](/funds/936753.md) | 2026-06-30 | $54.3m | 4,415,839 |  | Added +19,436 |
| [Sumitomo Mitsui Trust Group, Inc.](/funds/1475365.md) | 2026-06-30 | $46.2m | 3,752,965 |  | Unchanged |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $32.5m | 2,641,295 |  | Added +14,544 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $31.9m | 2,590,496 |  | Reduced −65,708 |
| [BAMCO INC /NY/](/funds/1017918.md) | 2026-06-30 | $27.1m | 2,204,959 |  | Added +4,610 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $25.6m | 2,084,192 |  | Added +293,579 |
| [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $21.9m | 1,784,126 |  | Added +2,699 |

## Recent filings

[All 505 filings](/companies/gcmg/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-10 | 20:17 ET | [10-Q](/filings/0001819796-26-000028.md) | Quarterly report, period 2026-06-30 | 0001819796-26-000028 |
| 2026-08-10 | 11:32 ET | [8-K](/filings/0001819796-26-000026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819796-26-000026 |
| 2026-06-12 | 20:05 ET | [8-K](/filings/0001213900-26-068263.md) | 5.07 Shareholder vote results | 0001213900-26-068263 |
| 2026-05-07 | 20:46 ET | [10-Q](/filings/0001819796-26-000024.md) | Quarterly report, period 2026-03-31 | 0001819796-26-000024 |
| 2026-05-07 | 15:12 ET | [8-K](/filings/0001819796-26-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819796-26-000019 |
| 2026-04-24 | 20:10 ET | [DEF 14A](/filings/0001140361-26-016693.md) | Proxy statement, period 2026-06-09 | 0001140361-26-016693 |
| 2026-02-19 | 22:28 ET | [10-K](/filings/0001819796-26-000010.md) | Annual report, period 2025-12-31 | 0001819796-26-000010 |
| 2026-02-10 | 13:01 ET | [8-K](/filings/0001819796-26-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819796-26-000003 |
| 2025-11-18 | 00:55 ET | [8-K](/filings/0001213900-25-111690.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-111690 |
| 2025-11-05 | 21:18 ET | [10-Q](/filings/0001819796-25-000025.md) | Quarterly report, period 2025-09-30 | 0001819796-25-000025 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001819796-26-000010.md), filed Feb 19, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/89d2b10c-04b4-4fe9-811d-7d7d264b9125)

## About the filer

- CIK: 1819796
- Tickers: GCMG
- Exchange: Nasdaq
- SIC code: 6282 Investment Advice
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.